The Know AML website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and Know AML cannot guarantee the accuracy of translated content. Know AML and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
BLOOD CANCER AWARENESS MONTH
September is Blood Cancer Awareness Month. Find out how you can help patients with acute myeloid leukemia and their caregivers better understand this complex disease by supporting our Keep MOVING, Keep LEARNING campaign.
Discover video stories from patients, caregivers, and healthcare professionals as they #TalkAML and share their experiences of mental health and wellbeing support from all over the world.
diagnosis
Diagnosing AML involves tests which look at cells in the blood and bone marrow. Tests include bone marrow biopsies, blood tests, and chromosomal and genetic studies.
View diagnosis stories
prognosis
There are a number of factors that can influence a patient's prognosis, including genetic and chromosomal abnormalities, age and overall health, a history of blood disorders or previous cancers, and response to chemotherapy.
View prognosis stories
treatment
The aim of treatment is to restore a balance of healthy blood cells and control abnormal leukemia cells, and will vary depending on the type of AML patient has. Treatment options include chemotherapy with anticancer or drugs targeted to particular leukemia cells, stem cell transplantation, or opportunities to take part in clinical trials.
View treatment stories
remission
Once there are no detectable leukemia cells in the blood or bone marrow, a patient is said to be in 'remission'. There may still be low levels of leukemia cells so patients will be closely observed and attend regular follow-ups.
View remission stories
relapse
Sometimes AML can return in patients who have been in remission, several months or even years later. Regular follow-ups are important so that relapse is detected early and treatment options can be discussed.
View relapse stories
Touch / hover to interact
BLOOD CANCER AWARENESS MONTH
September is Blood Cancer Awareness Month. Find out how you can help patients with acute myeloid leukemia and their caregivers better understand this complex disease by supporting our Keep MOVING, Keep LEARNING campaign.